Reports
Sale
Global Stem Cell Therapy Market Share, Size, Growth, Analysis, Forecast: By Treatment Type: Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy, Syngeneic Stem Cell Therapy; By Product Type: Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others; By Application; Regional Analysis; Competitive Landscape; 2023-2028
Global Stem Cell Therapy Market Outlook
The global stem cell therapy market size attained a value of USD 246 million in 2022. The market is further expected to grow at a CAGR of 18.50% between 2023 and 2028, to reach a value of USD 674 million in 2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Trends in the Market
Stem cell therapy is a specialised form of regenerative medicine that aims to repaid damaged cells by modulating the immune system and reducing inflammation. The capabilities of stem cell therapy offers immense potential for treatment of various medical conditions ranging from autoimmune and trauma injuries to inflammatory, orthopaedic, and neurological conditions. Instead of directly targeting the conditions, stem cell therapy aims at helping the body of the patient heal itself against the condition. Stem cell therapy utilises stem cells, the cells from which other cells are generated for specific functions, or derivatives of stem cells to trigger the body‘s healing.
- The increasing prevalence of chronic conditions such as cancer, musculoskeletal and cardiovascular diseases, and leukaemia, among others, is driving the stem cell therapy market growth. In addition, the market growth is getting fuelled by the rising health awareness, rising disposable income, and sedentary lifestyles led by the working population.
- The increasing geriatric population, along with the surge in oncological, neurological, and orthopaedic conditions cases associated with them is anticipated to provide impetus to the stem cell therapy market in the forecast period. The market is anticipated to be aided by the increasing prevalence of wounds and injuries, infused by the growing inclination of youth towards sports and adventure.
- The rising healthcare expenditure and technological advancements in the healthcare infrastructure across the emerging economies are improving the diagnosis and treatment standards across the healthcare units which are further boosting the market growth.
- The growing research and development activities, favoured by fundings and initiatives by various governments, aimed towards innovating in the field of stem cell research are the crucial stem cell therapy market trends.
Market Analysis
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on treatment type, the market is segmented into allogeneic stem cell therapy, autologous stem cell therapy, syngeneic stem cell therapy. On the basis of product type, the stem cell therapy market is classified into adult stem cell, human embryonic cell, and pluripotent stem cell, among others. By application, the market is categorised into musculoskeletal disorders, neurological disorders, oncology disorders, cardiovascular disorders, cancer, and wounds and injuries, among others. The regional markets for stem cell therapy are divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global stem cell therapy market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
- Thermo Fisher Scientific
- Bayer AG
- Takeda Pharmaceutical Company Limited
- MEDIPOST Co., Ltd.
- JCR Pharmaceuticals Co., Ltd.
- Astellas Pharma Inc.
- Mesoblast Ltd.
- Novadip Biosciences S.A.
- Nuvasive Inc
- Amgen Inc
- Others
Market Share by Treatment Type
The allogeneic stem cell therapy segment is expected to witness a healthy growth in the forecast period, increasing its stem cell therapy market share. In this treatment procedure, stem cells are matched from a donor and transplanted into the patient whose immune system gets a boost after other types of treatment are administered. While the transplanted stem cells do help in improving the immune system of the patient and in fighting against conditions such as cancers, there is a risk of rejection with the stem cells getting targeted and destroyed by the patient’s immune system.
Syngeneic stem cell therapy, based on treatment type, has a high success rate, however, is restricted in applications as stem cells are sourced from identical twins of the patient. This type of stem cell therapy is uses to treat various types of conditions such as Hodgkin lymphoma, leukaemia, multiple myeloma, Myelodysplastic syndrome, Non-Hodgkin lymphoma, severe aplastic anaemia, and testicular cancer, among others. Moreover, in this therapy, as stem cells are donated by healthy identical twins, reducing risks of rejection or host versus graft disease, increasing the success rate of the procedure significantly.
Market Share by Product Type
Based on product type, the human embryonic cell segment accounts for a significant share in the stem cell therapy market. This can be attributed to the versatility of this type of cell which makes it effective in the treatment and repair of diseased organs or tissues. In addition, human embryonic cell accelerate the therapy process by dividing into more stem cells than any other product type. With the increase in in-vitro fertilisation clinics and operations, extracting human embryonic cells has become easier.
On the other hand, the adult stem cell segment is expected to witness a heightened growth in the forecast period. Adult stem cells are present in the most critical areas of the body such as intestine, muscle, brain, and heart. Hence, these types of cells can facilitate the regeneration of cells which can treat chronic heart or muscle-related conditions. The targeted applications of these cells and easy availability amongst a growing population is further expected to influence the stem cell therapy market price.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
Thermo Fisher Scientific is a key supplier of scientific instruments, reagents, and consumables. The company caters to the demands of medical science by providing custom-tailored solutions, biotech products, medical devices, pharmaceuticals, drug innovations, and medicines, among others. Thermo Fisher Scientific was founded in 1956 and is headquartered in Massachusetts, United States.
Bayer AG is a leading pharmaceutical company which develops, discovers, innovates, manufactures, and markets products which cater to the demands of human health treatment and agriculture. The company offers products which are applied in the treatment of cardiovascular diseases, women’s health, cancer, and ophthalmological diseases, among others. Bayer AG was established in 1863 in Barmen, Germany.
Takeda Pharmaceutical Company Limited is a global research-based company which focuses on developing high-end pharmaceuticals. This company facilitates research and development activities and clinical trials, with a focus on oncological, neuroscience, gastroenterology, and plasma-derived therapies, among others. It was founded in 1781 and is headquartered in Osaka, Japan.
Other market players include MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Astellas Pharma Inc., Mesoblast Ltd., Novadip Biosciences S.A., Nuvasive Inc, and Amgen Inc, among others.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Stem Cell Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Stem Cell Therapy Historical Market (2018-2022)
8.3 Global Stem Cell Therapy Market Forecast (2023-2028)
8.4 Global Stem Cell Therapy Market by Treatment Type
8.4.1 Allogeneic Stem Cell Therapy
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Autologous Stem Cell Therapy
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Syngeneic Stem Cell Therapy
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.5 Global Stem Cell Therapy Market by Product Type
8.5.1 Adult Stem Cell
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Human Embryonic Cell
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Pluripotent Stem Cell
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Others
8.6 Global Stem Cell Therapy Market by Application
8.6.1 Musculoskeletal Disorders
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Neurological Disorders
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Oncology Disorders
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Cardiovascular Disorders
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Cancer
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
8.6.6 Wounds and Injuries
8.6.6.1 Market Share
8.6.6.2 Historical Trend (2018-2022)
8.6.6.3 Forecast Trend (2023-2028)
8.6.7 Others
8.7 Global Stem Cell Therapy Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Stem Cell Therapy Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Stem Cell Therapy Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Stem Cell Therapy Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Stem Cell Therapy Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Stem Cell Therapy Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Thermo Fisher Scientific
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Bayer AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Takeda Pharmaceutical Company Limited
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 MEDIPOST Co., Ltd.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 JCR Pharmaceuticals Co., Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Astellas Pharma Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Mesoblast Ltd.
15.2.7.1 Company Overview
15.2.7.2 Product Portfolio
15.2.7.3 Demographic Reach and Achievements
15.2.7.4 Certifications
15.2.8 Novadip Biosciences S.A.
15.2.8.1 Company Overview
15.2.8.2 Product Portfolio
15.2.8.3 Demographic Reach and Achievements
15.2.8.4 Certifications
15.2.9 Nuvasive Inc
15.2.9.1 Company Overview
15.2.9.2 Product Portfolio
15.2.9.3 Demographic Reach and Achievements
15.2.9.4 Certifications
15.2.10 Amgen Inc
15.2.10.1 Company Overview
15.2.10.2 Product Portfolio
15.2.10.3 Demographic Reach and Achievements
15.2.10.4 Certifications
15.2.11 Others
16 Key Trends and Developments in the Market
List Key of Figures and Tables
1. Global Stem Cell Therapy Market: Key Industry Highlights, 2018 and 2028
2. Global Stem Cell Therapy Historical Market: Breakup by Treatment Type (USD Million), 2018-2022
3. Global Stem Cell Therapy Market Forecast: Breakup by Treatment Type (USD Million), 2023-2028
4. Global Stem Cell Therapy Historical Market: Breakup by Product Type (USD Million), 2018-2022
5. Global Stem Cell Therapy Market Forecast: Breakup by Product Type (USD Million), 2023-2028
6. Global Stem Cell Therapy Historical Market: Breakup by Application (USD Million), 2018-2022
7. Global Stem Cell Therapy Market Forecast: Breakup by Application (USD Million), 2023-2028
8. Global Stem Cell Therapy Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Stem Cell Therapy Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Stem Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Stem Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Stem Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Stem Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Stem Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Stem Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Stem Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Stem Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Stem Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Stem Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Stem Cell Therapy Market Structure
Key Questions Answered in the Report
The market reached a value of USD 246 million in 2022.
The market is estimated to grow at a CAGR of 18.50% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach a value of USD 674 billion in 2028.
The increasing awareness pertaining to stem cell therapy, growing prevalence of chronic conditions such as cancer, musculoskeletal and cardiovascular diseases, and advancements in stem cell therapy technology are the major drivers of the market.
The key trends in the market include the increasing geriatric population, improvements in healthcare infrastructure, rising funding towards the research and development activities related to stem cells, and advancements in stem cell sourcing.
Allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy are the different treatment types in the market.
The various product types in the market are adult stem cell, human embryonic cell, and pluripotent stem cell, among others.
Musculoskeletal disorders, neurological disorders, oncology disorders, cardiovascular disorders, cancer, and wounds and injuries, among others, are the different applications included in the market report.
Stem cell therapy involves administration of stem cells into a patient that help regenerate and repair damaged tissues or organs.
Thermo Fisher Scientific, Bayer AG, Takeda Pharmaceutical Company Limited, MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Astellas Pharma Inc., Mesoblast Ltd., Novadip Biosciences S.A., Nuvasive Inc, and Amgen Inc, among others, are the key players in the stem cell therapy market, according to the report.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER